Skip to content

Outset Medical, Inc. OM Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

DaVita logo
DaVitaDVA
$1.26B+99.5%
Medtronic logo
MedtronicMDT
$1.75B
Haemonetics logo
HaemoneticsHAE
$0
Tenet Healthcare logo
Tenet HealthcareTHC
$14M+1,300%
Universal Health Services logo
Universal Health ServicesUHS
$40K-100.0%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$291.16M

Other financials

Income statement

See full
Revenue$27.9M-6.3%
Gross profit$12.1M+9.3%
Operating income-$16.9M-3.2%
Net income-$19.0M+26.4%
EPS (diluted)-$1.03+71.9%

Balance sheet

See full
Cash & equivalents$30.6M-59.7%
Total debt$101.6M+3.5%
Total equity$111.7M-34.3%
Total assets$249.5M-17.2%

Cash flow

See full
Operating cash flow-$12.8M+50.0%
CapEx$65.0K-47.2%
Free cash flow-$12.9M+49.9%

Valuation

See full
Market cap$80.08M-75.5%
Enterprise value$151.13M-61.9%
P/S0.7×-2.1×

Profitability

See full
Gross margin40.6%+4.7pp
Operating margin-57.2%-12.9pp
Net margin-63.7%-16.7pp
FCF margin-29.1%-11.5pp

Returns & leverage

See full
Return on equity-53.2%-14.8pp
Debt / equity0.9×+0.3×
Current ratio6.3×-2.1×

Where this comes from

Reported directly by Outset Medical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfLongTermDebt.

The official record: Outset Medical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Outset Medical, Inc.'s debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Outset Medical, Inc.'s debt issuance proceeds?
Outset Medical, Inc. (OM) reported debt issuance proceeds of $0 in Q1 2026.
How has Outset Medical, Inc.'s debt issuance proceeds changed year-over-year?
Outset Medical, Inc.'s debt issuance proceeds decreased by 100.0% year-over-year, from $98.27M to $0.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.